First rifapentine product prequalified
M
-
TB336: Rifapentine - 150mg - Film-coated tablets - Sanofi-Aventis U.S. LLC - USA
5th Invitation to Manufacturers of Medicinal Products for Treatment of Neglected Tropical Diseases
M
The following products were added:
-
Miltefosine 10mg and 50mg capsule
BTIF revised
M
The revisions to the BTIF (Bioequivalence Trial Information Form) include the following changes to facilitate study assessment:
12th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) for prequalification
M
The following active pharmaceutical ingredients (APIs) were added:
- Benzathine benzylpen
11th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs)
M
The 11th invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API prequalification to the WHO Prequalification Team: medicines (PQTm
Active Pharmaceutical Ingredient (API) Prequalified
M
Desogestrel (WHOAPI-479) manufactured by Hunan KYF Pharmaceutical Co. Ltd. has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
24th Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit (PQT)
M
The invitation to Manufacturers of Antimalarial Medicines to submit an Expre
23rd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of Antituberculosis Medicines to submit an Expression of Interes
Active Pharmaceutical Ingredient (API) Prequalified
M
Lamivudine, manufactured by SMS Pharmaceuticals Limited, has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.